Plea for Urgent Financial Aid for Girl with Rare Disease: Delhi HC seeks Centre's reply

New Delhi: The Delhi High Court on Monday sought the Centre’s response regarding a plea filed by the mother of a young girl suffering from Spinal Muscular Atrophy (SMA). The girl, who requires an expensive gene therapy Zolgensma, has requested the court’s intervention to expedite the process of securing financial assistance for her treatment.

In the petition filed through her mother, the girl has said she is suffering from Spinal Muscular Atrophy (SMA) Type 1, a rare genetic disease that causes muscle weakness and is the most severe form of SMA that requires a life-saving gene therapy called Zolgensma.

According to the PTI report, Justice Sanjeev Narula issued a notice to the Centre and asked its counsel to get instructions from the authorities concerned.

The petitioner's counsel said the gene therapy would cost around Rs 17.5 crore and since the girl comes from a middle-class family, she does not have the means to bear the exuberant cost of the treatment.

Also Read:Ensure funds for treatment of kids with rare diseases: Delhi HC directs Centre

The counsel relied on the National Policy for Rare Diseases, according to which the government has identified and categorised such diseases.

The lawyer said the petitioner had made a request to the Union Ministry of Health and Family Welfare on August 16, seeking help for the procurement of Zolgensma and the representation is pending consideration.

The court was informed that the petitioner is registered with the All India Institute of Medical Sciences (AIIMS), one of the centres of excellence according to the policy, news agency PTI reported.

However, for the procurement, the permission has to come from the National Rare Diseases Committee (NRDC), the petitioner's counsel said.

The petitioner has sought a direction to fast-track the process of financial assistance and procurement of medicines. She has also sought directions to the NRDC to take a decision after receiving recommendations from the centre of excellence concerned.

Also Read:Delhi HC asks Centre to release Rs 10 Crore to AIIMS for treatment of rare diseases